Evidence map›Paper›PMID 30900113›Full record

ArticleVeterinary research communications2019

Ov2 is a modulator of OvHV-2 RTA mediated gene expression.

Inga Dry, Katie Nightingale, Jack Ferguson, John Hopkins, Robert Dalziel

Abstract read
In one paragraph

Article in Veterinary research communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Regulation of Ov2 by virus encoded microRNAs.Veterinary research communications · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Inga DryThe Roslin Institute & R(D)SVS, University of Edinburgh, Edinburgh, Midlothian, EH25 9RG, UK. Inga.Dry@roslin.ed.ac.uk.ORCID http://orcid.org/0000-0002-4593-8102
Katie NightingaleThe Roslin Institute & R(D)SVS, University of Edinburgh, Edinburgh, Midlothian, EH25 9RG, UK.
Jack FergusonThe Roslin Institute & R(D)SVS, University of Edinburgh, Edinburgh, Midlothian, EH25 9RG, UK.
John HopkinsThe Roslin Institute & R(D)SVS, University of Edinburgh, Edinburgh, Midlothian, EH25 9RG, UK.
Robert DalzielThe Roslin Institute & R(D)SVS, University of Edinburgh, Edinburgh, Midlothian, EH25 9RG, UK.

Funding

Biotechnology and Biological Sciences Research Council BBS/E/D/20002173Biotechnology and Biological Sciences Research Council BBS/E/D/20241864
6 · The paper itself

Abstract

Ovine herpesvirus-2 (OvHV-2) is the causative agent of the sheep-associated form of malignant catarrhal fever, a usually fatal lymphoproliferative disease of bison, deer and cattle. Malignant catarrhal fever is a major cause of cattle loss in Africa with approximately 7% affected annually; and in North America has significant impact on bison farming. Research into the mechanisms by which OvHV-2 induces disease in susceptible species has been hampered by a lack of a cell culture system for the virus. Ov2 is a bZIP protein encoded by OvHV-2. Proteins with bZIP domains in other herpesviruses, such as the Kaposi's sarcoma-associated herpesvirus K8 protein and the BZLF1 protein of Epstein-Barr virus are known to play important roles in lytic virus replication. Using a reporter based system, we demonstrate that Ov2 can modulate the activity of the major virus transactivator (Replication and Transcriptional Activator protein, RTA) to 1) drive expression of viral genes predicted to be required for efficient reactivation of the virus, including ORF49; and 2) differentially regulate the expression of the two virus encoded Bcl-2 homologues Ov4.5 and Ov9.

Indexed as

GammaherpesvirinaeGene Expression Regulation, ViralTrans-ActivatorsViral ProteinsTrans-ActivatorsViral ProteinsGene expressionOv2Ovine herpesvirus-2

Identifiers

PMID30900113
PMCPMC6525121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.